Sherief Abd-Elsalam to Adult
This is a "connection" page, showing publications Sherief Abd-Elsalam has written about Adult.
Connection Strength
0.215
-
Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study. J Med Virol. 2021 Oct; 93(10):5833-5838.
Score: 0.016
-
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg. 2020 10; 103(4):1635-1639.
Score: 0.015
-
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection. Infect Disord Drug Targets. 2020; 20(3):389-395.
Score: 0.014
-
Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients. Eur J Gastroenterol Hepatol. 2019 04; 31(4):499-502.
Score: 0.013
-
Association of serum level of vitamin D and VDR polymorphism Fok1 with the risk or survival of pancreatic cancer in Egyptian population. Indian J Cancer. 2019 Apr-Jun; 56(2):130-134.
Score: 0.013
-
Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial. BMC Gastroenterol. 2019 Feb 04; 19(1):23.
Score: 0.013
-
Genetic Susceptibility in Family Members of Egyptian Hepatitis C Virus Infected Patients: Role of Interleukin-12 B Gene Polymorphism. Infect Disord Drug Targets. 2019; 19(1):81-87.
Score: 0.013
-
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation. Endocr Metab Immune Disord Drug Targets. 2019; 19(2):185-188.
Score: 0.013
-
Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice. Infect Disord Drug Targets. 2019; 19(2):179-184.
Score: 0.013
-
Randomized trial of preoperative administration of oral pregabalin for postoperative analgesia in patients scheduled for radiofrequency ablation of focal lesions in the liver. Int J Hyperthermia. 2018 12; 34(8):1367-1371.
Score: 0.012
-
Association of IL-12 B Gene Polymorphism with Staging of Liver Disease in Chronic HCV Patients. Infect Disord Drug Targets. 2018; 18(2):122-128.
Score: 0.012
-
Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study. Environ Sci Pollut Res Int. 2018 Feb; 25(6):5459-5464.
Score: 0.012
-
High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest. 2018 Feb; 47(2):169-180.
Score: 0.012
-
Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection. Helicobacter. 2017 Oct; 22(5).
Score: 0.012
-
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021 09; 225(3):289.e1-289.e17.
Score: 0.004
-
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 04 15; 12(1):2349.
Score: 0.004
-
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar; 166(3):949-954.
Score: 0.004
-
Utility of Lung Ultrasound in Decision-making to Prioritize Hospital Admission for COVID-19 Patients: A Developing Country Perspective. Curr Med Imaging. 2021; 17(12):1473-1480.
Score: 0.004
-
Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis. Antiinflamm Antiallergy Agents Med Chem. 2020; 19(2):140-148.
Score: 0.004
-
Helicobacter pylori infection and risk of salmonella infection. Medicine (Baltimore). 2019 Feb; 98(6):e14335.
Score: 0.003
-
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt. Endocr Metab Immune Disord Drug Targets. 2019; 19(7):1005-1011.
Score: 0.003
-
Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019 Feb; 113:86-91.
Score: 0.003